512 related articles for article (PubMed ID: 10531386)
1. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression.
Kislinger T; Fu C; Huber B; Qu W; Taguchi A; Du Yan S; Hofmann M; Yan SF; Pischetsrieder M; Stern D; Schmidt AM
J Biol Chem; 1999 Oct; 274(44):31740-9. PubMed ID: 10531386
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
Basta G; Lazzerini G; Massaro M; Simoncini T; Tanganelli P; Fu C; Kislinger T; Stern DM; Schmidt AM; De Caterina R
Circulation; 2002 Feb; 105(7):816-22. PubMed ID: 11854121
[TBL] [Abstract][Full Text] [Related]
3. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
Schmidt AM; Yan SD; Wautier JL; Stern D
Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
[TBL] [Abstract][Full Text] [Related]
6. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion.
Yeh CH; Sturgis L; Haidacher J; Zhang XN; Sherwood SJ; Bjercke RJ; Juhasz O; Crow MT; Tilton RG; Denner L
Diabetes; 2001 Jun; 50(6):1495-504. PubMed ID: 11375353
[TBL] [Abstract][Full Text] [Related]
7. Activation of tubular epithelial cells in diabetic nephropathy.
Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
[TBL] [Abstract][Full Text] [Related]
8. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway.
Guo ZJ; Niu HX; Hou FF; Zhang L; Fu N; Nagai R; Lu X; Chen BH; Shan YX; Tian JW; Nagaraj RH; Xie D; Zhang X
Antioxid Redox Signal; 2008 Oct; 10(10):1699-712. PubMed ID: 18576917
[TBL] [Abstract][Full Text] [Related]
9. The biology of the receptor for advanced glycation end products and its ligands.
Schmidt AM; Yan SD; Yan SF; Stern DM
Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities.
Lalla E; Lamster IB; Stern DM; Schmidt AM
Ann Periodontol; 2001 Dec; 6(1):113-8. PubMed ID: 11887453
[TBL] [Abstract][Full Text] [Related]
11. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
13. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.
Wautier MP; Chappey O; Corda S; Stern DM; Schmidt AM; Wautier JL
Am J Physiol Endocrinol Metab; 2001 May; 280(5):E685-94. PubMed ID: 11287350
[TBL] [Abstract][Full Text] [Related]
14. The receptor for advanced glycation end products mediates lung endothelial activation by RBCs.
Mangalmurti NS; Friedman JL; Wang LC; Stolz D; Muthukumaran G; Siegel DL; Schmidt AM; Lee JS; Albelda SM
Am J Physiol Lung Cell Mol Physiol; 2013 Feb; 304(4):L250-63. PubMed ID: 23275625
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs.
Lieuw-a-Fa ML; Schalkwijk CG; Engelse M; van Hinsbergh VW
Thromb Haemost; 2006 Feb; 95(2):320-8. PubMed ID: 16493495
[TBL] [Abstract][Full Text] [Related]
16. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of advanced glycation end-products on renal tubular cell inflammation.
Tang SC; Chan LY; Leung JC; Cheng AS; Lin M; Lan HY; Lai KN
Nephrology (Carlton); 2011 May; 16(4):417-25. PubMed ID: 21143336
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line.
Hayakawa E; Yoshimoto T; Sekizawa N; Sugiyama T; Hirata Y
J Atheroscler Thromb; 2012; 19(1):13-22. PubMed ID: 22082983
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
Huttunen HJ; Fages C; Rauvala H
J Biol Chem; 1999 Jul; 274(28):19919-24. PubMed ID: 10391939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
